Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.

Journal

British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 28 5 2019
medline: 28 5 2019
entrez: 25 5 2019
Statut: ppublish

Résumé

The additional information of this manuscript originally stated that the authors declare no competing interests. This statement was incorrect, and should instead have stated the following:M.C.H. has the following competing interests to declare: Equity interest at Molecular MD; Consulting at Molecular MD, Blueprint Medicines, Deciphera Pharmaceuticals; Expert Testimony at Novartis; Licensed patent with royalty payments at Novartis. The remaining authors have no competing interests to declare.The authors apologise for any convenience this may have caused.

Identifiants

DOI: 10.1038/s41416-019-0487-5 PMID: 31123346 PMC: PMC6738067
pubmed: 31123346
doi: 10.1038/s41416-019-0487-5
pii: 10.1038/s41416-019-0487-5
pmc: PMC6738067
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

281

Commentaires et corrections

Type : ErratumFor

Auteurs

César Serrano (C)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA. cserrano@vhio.net.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. cserrano@vhio.net.
Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology; Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. cserrano@vhio.net.

Adrián Mariño-Enríquez (A)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA.

Derrick L Tao (DL)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA.

Julia Ketzer (J)

Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Grant Eilers (G)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA.

Meijun Zhu (M)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA.

Channing Yu (C)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, USA.
Daiichi Sankyo Inc., Basking Ridge, NJ, USA.

Aristotle M Mannan (AM)

Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, USA.

Brian P Rubin (BP)

Department of Molecular Genetics, Lerner Research Institute and Cleveland Clinic, 9500, Euclid Ave, Cleveland, OH, USA.

George D Demetri (GD)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Ludwig Center for Cancer Research at Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

Chandrajit P Raut (CP)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Division of Surgical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, 75 Francis Street, Boston, MA, USA.

Ajia Presnell (A)

Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA.

Arin McKinley (A)

Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA.

Michael C Heinrich (MC)

Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA.
ORCID: 0000-0003-3790-0478

Jeffrey T Czaplinski (JT)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Ewa Sicinska (E)

Department of Oncologic Pathology, Dana Farber Cancer Institute, Boston, MA, USA.

Sebastian Bauer (S)

Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Suzanne George (S)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Jonathan A Fletcher (JA)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA. jfletcher@partners.org.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jfletcher@partners.org.

Classifications MeSH